AlphaYouRK
Schedule 13G filing
RICKEL KENNETH disclosed a 5.7% stake in Hepion Pharmaceuticals, Inc. (HEPA)
RICKEL KENNETH reported owning 5.7% of Hepion Pharmaceuticals, Inc. (HEPA) (5,250,000 shares) in a Schedule 13G filed Sep 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 15, 2026
- Source
- Schedule 13G
More HEPA insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.